Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary Malignancy of the Central Nervous System
NCT ID: NCT06485310
Last Updated: 2026-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
58 participants
INTERVENTIONAL
2026-03-31
2028-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will be randomized into two groups :
* group A) intervention: usual care + nurse teleconsultation for psychological support
* group B) control: usual care alone
Enrolment = Day0 (D0)
Participants will :
* groups A and B: D0: complete 4 questionnaires (Quality of Life, Screening for Distress, Screening for Anxiety and Depression, Social Support Questionnaire)
* Group A : D0+2/4 das : nursing teleconsultation for psychological support
* Groups A and B: D0+10days : telephone call to complete the same 4 questionnaires as at inclusion
* Group A : D0+15days: semi-directive interview, at home, for voluntary patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Psychological Factors Influencing Cancer Post-traumatic Growth
NCT06278558
The Effects of Multi-Psycho-Oncology Care Courses
NCT05776680
Evaluation of a Telephone Care Nurse in the Management of Patients With Cancer and Treated by Oral Chemotherapy
NCT02459483
Development and Application of Intervention Program to Improve Mental Health and Quality of Life of Solid Tumor Survivors and Caregivers
NCT06969742
Telehealth in an Ambulatory Oncology Phase I Clinical Trial Unit
NCT07069868
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For the patient :
* Reduction in pre-treatment psychological distress
* Reduced pre-treatment anxiety and depression
* Better understanding of disease and treatments
* Better adherence to the care proposed in the treatment pathway
* Reduced stress during first hospital treatment
For healthcare professionals :
* Early detection of psychological distress
* Early detection of unmet needs and appropriate individualized responses
* Establishment of a climate of trust between patient and caregiver
* Improved professional practices
For the healthcare system :
* Lower healthcare costs (fewer anxiolytic treatments, etc.)
* Therapy to be integrated into the treatment pathway of patients with central nervous system cancer
* Reduced socio-territorial inequalities in healthcare provision
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TELECONSULTATION
Teleconsultation with a nurse for psychological support, after the diagnosis has been announced, before hospitalization for the first treatment (chemotherapy, surgery, radiotherapy) in addition to the standard practice.
Teleconsultation for psychological support
Teleconsultation with a nurse for psychological support, after the diagnosis has been announced, before hospitalization for the first treatment (chemotherapy, surgery, radiotherapy) in addition to the standard practice
NO TELECONSULTATION
The control group will be cared for according to standard practice (without teleconsultation)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Teleconsultation for psychological support
Teleconsultation with a nurse for psychological support, after the diagnosis has been announced, before hospitalization for the first treatment (chemotherapy, surgery, radiotherapy) in addition to the standard practice
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* being treated for a primary malignant tumor of the central nervous system (positive biopsy)
* with a Mini-Mental State score greater than 24
* not receiving first-line treatment (chemotherapy, targeted radiotherapy, surgery)
* with a distress score above 3 on the Psychological Distress Thermometer
* have access to computer equipment equipped with a microphone and webcam (smartphone, computer)
* able to read, write and speak French
* have given free and informed consent
* being affiliated to a social security scheme
Exclusion Criteria
* with recurrent cancer of the cerebral nervous system
* having begun first-line treatment (drug therapy, curative surgery, radiotherapy or palliative care)
* under guardianship, curatorship or deprived of liberty
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de la Réunion
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Reunion Island - Neurosurgery department
Saint-Pierre-des-Corps, Reunion, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024/CHU/02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.